课题基金 / 基金详情

Development of a new method of gene therapy for head and neck cancer patients by electroporation of plasmid vector

Development of a new method of gene therapy for head and neck cancer patients by electroporation of plasmid vector
通过质粒载体电穿孔开发头颈癌基因治疗新方法
批准号:
09672053
负责人:
YOSHIDA Hideo
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

YOSHIDA Hideo的其他基金

相似基金

相关文献

中文摘要
翻译
本实验旨在为头颈部肿瘤患者的基因治疗提供一种新的方法。首先,我们尝试将自杀基因HSV-tk引入EB病毒质粒载体(pEBETA 3-CAG)中。将pEBETA 3-CAG-HSV-tk分别用电穿孔法和脂质体复合法转染人涎腺癌细胞株HSG和TYS,均获得了极高的表达。然而,我们未能将这些EBETA质粒载体导入由HSG细胞形成的裸鼠肿瘤中。然后,我们使用普通质粒载体pGL 3-control检测了体内转染效率,该质粒载体含有SV 40早期启动子驱动的荧光素酶基因作为报告基因。在几种电穿孔条件下,用pGL 3-control转染HSG裸鼠肿瘤。转染后两天,从小鼠中切除肿瘤,并分析组织提取物的荧光素酶活性。结果发现,用5 μ g质粒经皮电击1 μ g,99 μ s转染HSG裸鼠肿瘤。8倍方脉冲是体内电穿孔测试的最有效条件。为了检测转染基因产物在细胞中的定位,我们使用了含有由CMV-IE启动子驱动的绿色荧光蛋白(GFP)的pEGFP-C3质粒。转染后两天,从小鼠中切除肿瘤,并制备冷冻切片。在荧光显微镜下观察到GFP在部分细胞中的表达,并成功地将质粒载体电穿孔导入裸鼠肿瘤中。这些结果表明,该方法可用于人头颈癌的基因治疗,如果转染效率将得到提高。
英文摘要
This experiment was conducted to develop a new method of gene therapy for head and neck cancer patients. First, we attempted to introduce a suicidal gene, HSV-tk, in an EB virus-plasmid vector (pEBETA3-CAG). When we transfected HSG cells or TYS cells, both are salivary gland cancer cells, with pEBETA 3-CAG-HSV-tk in vitro by electroporation or liposome complex method, extremely high expression of the transfected gene was observed in both HSG cells and TYS cells. However, we failed to introduce these EBETA-plasmid vector into the nude mouse tumors formed by HSG cells. Then we examined the in vivo transfection efficiency using a common plasmid vector, pGL3-control containing luciferase gene as a reporter driven by SV40 early promoter. HSG nude mouse tumor was transfected by pGL3-control in several conditions for electroporation. Two days after transfection, tumors were excised from mice, and the tissue extracts were analysed for luciferase activity. It was found that transfection of HSG nude mouse tumors with 5 mug of the plasmid by per-cutaneous electric-shock at 1 kv, 99 musec. for 8 times square pulse is the most effective condition tested for in vivo electroporation. In order to examine the localization of the transfected gene products in the cells, we used pEGFP-C3 plasmid, containing green fluorescent protein (GFP) driven by CMV-IE promoter. Two days after transfection, tumors were excised from mice, and frozen sections were prepared. We obserbed the expression of GFP fluorescent in some of the cells in the tumors under fluorescent microscopy.We succeed to introduce plasmid vector into nude tumors by electroporation. These results suggests that these method can be applied for human head and neck cancer gene-therapy, if the transfection efficiency will be improved.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawamata H, Uchida D, Hamano H, Kimura-Yanagawa T, Nakashiro K, Hino S: "Omotehara F, Yoshida H and Sato M : Active-MMP2 in cancer cell nests of oral cancer patients : Correlation with lymph node metastasis" International Journal of Oncology. 13 (4). 699-
Kawamata H、Uchida D、Hamano H、Kimura-Yanakawa T、Nakashiro K、Hino S:“Omotehara F、Yoshida H 和 Sato M:口腔癌患者癌细胞巢中的活性 MMP2:与淋巴结转移的相关性”国际期刊
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okamoto M, Kasetani H, Kaji R, Goda H, Ohe G, Yoshida H And Sato M: "Cis-diammine-dichloroplatinum and 5-fluorouracil are potent inducer of the cytokines and natural killer cell activity in vivo and in vitro." Cancer Immunology Immunotherapy. 47 (4). 233-
Okamoto M、Kasetani H、Kaji R、Goda H、Ohe G、Yoshida H 和 Sato M:“顺式二氨二氯铂和 5-氟尿嘧啶是体内和体外细胞因子和自然杀伤细胞活性的有效诱导剂。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawamata et al.: "Haematogeneous cytokeratin20 mRNA as a predictive marker for recurrenca in oral canser pofisents." British Journal of Canser. (印刷中). (1999)
Kawamata 等人:“Haematogeneous cytokeratin20 mRNA 作为口腔癌复发的预测标记。”英国癌症杂志(1999 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Establishment of a novel therapeutic approach targeting cancer stem cells of neuroblastoma using onclytic virus
    • 批准号:
      22591976
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      YOSHIDA Hideo
    • 依托单位:
    Control and Enhancement of Successive Reaction of Steam Reforming of Dimethyl Ether in a Pressure Gradient in Micro Nozzle
    • 批准号:
      21360096
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2009
    • 负责人:
      YOSHIDA Hideo
    • 依托单位:
    The effect of professional oral health care on improving autoimmune disease
    • 批准号:
      20390536
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2008
    • 负责人:
      YOSHIDA Hideo
    • 依托单位:
    Immune system of the intestinal mucosa and effects of probiotics in inflammatorybowel disease
    • 批准号:
      18591950
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.95万
    • 财政年份:
      2006
    • 负责人:
      YOSHIDA Hideo
    • 依托单位:
    海外基金